Katherine Wade Email and Phone Number

• Analyzed and prepared DNA and amino acid sequence listings and designed processes to increase firm's sequence listing capacity by >400% per listing.• Performed competitor third-party monitoring and developed processes to increase efficiency and decrease client costs by over 40%. • Performed freedom-to-operate, invalidity, and diligence searches using Patbase, PAIR, Espacenet, Patentscope, Pubmed, Genbank, Lens and BLAST databases. • Drafted comprehensive descriptions of scientific experiments and data across a variety of biotechnologies including mRNA vaccines, antibodies, small molecules, and gene editing• Prepared substitute specifications and replacement figures in response to USPTO actions• Designed prior art management systems to support complex, client-specific, Information Disclosure Statement citation practices

• Summer 2022, Summer 2023, Summer 2024• Drafted patent specifications, claims, and USPTO/EPO office action responses, including responses to 101, 102, 103, 112, novelty and inventive step rejections • Performed patentability analyses and drafted opinions for mRNA vaccine and antibody technologies• Crafted a licensing package for client IP portfolio including comprehensive worldwide prosecution strategy and freedom-to-operate search with invalidity and non-infringement positions• Conducted extensive examiner research by analyzing prosecution histories of recently patented cases and provided resulting strategic insights

• Insulating materials specialist on four-person team charged with performing forensic failure analysis for client high-value electrical assets. • Developed and validated novel chemical testing methods related to sulfur content in insulating materials.• Designed data analytics processes to increase accuracy and speed of data analysis. • Tested and analyzed over 3000 insulating liquid samples to determine their chemical, electrical, and physical properties using standard industry protocols. • Demonstrated efficient, organized performance to comply with client deadlines and decrease sample backlog.

• Reviewed prior art and clinical trials related to therapeutic use of fecal microbiota transplants in humans and lab animals and correlated data sets for future research and development.• Revised protocols for toxicity testing in lab animals for dermal, oral and rectal doses of a proprietary biocide.

Investigated methods of synthesis for novel ruthenium complexes to be used as improved photosensitizers.

• Independently designed and performed experiments in development of a high throughput screening fluorescence polarization immunoassay related to pharmaceutical research.• Performed literature searches to guide and inform research. • Organized and presented results• Trained in research and development processes within the field of biotechnology.